Bao Lu Wang
Shaanxi Normal University
6 Papers
19 Citations
Bao Lu Wang is an academic researcher from Shaanxi Normal University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Enhancement of apoptosis by sonodynamic therapy with protoporphyrin IX in isolate sarcoma 180 cells.
TL;DR: Results indicated that PPIX-mediated sonodynamic effect could exert its antitumor effect by triggering apoptosis in S180 cells through a Fas-mediated signal transduction pathway.
20
Research Progress in the Pharmacological Activities, Toxicities, and Pharmacokinetics of Sophoridine and Its Derivatives
Qiong Tang,Yao Liu,Xi Peng,Bao Lu Wang,Fei Luan,Nan Zeng +5 more
TL;DR: This article comprehensively summarize the biological activities, toxicity, and pharmacokinetic characteristics of sophoridine and its derivatives, as currently reported in publications, as it attempt to provide an overall perspective on Sophoridine analogs and the prospects of its application clinically.
8
Fengreqing Oral Liquid Exerts Anti-Inflammatory Effects by Promoting Apoptosis and Inhibiting PI3K/AKT and NF-κB Signaling Pathways
TL;DR: The results suggest that FOL may exert anti-inflammatory effects by inhibiting the PI3K/AKT signaling pathway to promote apoptosis and leading to attenuated activation of the NF-κB signaling pathway.
4
Dddt_a_339555 191..212
Qi Tang,Yao Liu,Xi Peng,Bao Lu Wang,Fei Luan,Nan Zeng +5 more
TL;DR: This article comprehensively summarize the biological activities, toxicity, and pharmacokinetic characteristics of Sophoridine and its derivatives, as currently reported in publications, as to provide an overall perspective on sophoridine analogs and the prospects of its application clinically.
Sophoridine Suppresses Herpes Simplex Virus Type 1 Infection by Blocking the Activation of Cellular PI3K/Akt and p38 MAPK Pathways
TL;DR: Sri can directly inactivate viral particles and block some stages in the life cycle of HSV-1 after adsorption and could be a promising therapeutic candidate against HSv-1 via the modulation of cellular PI3K/Akt and p38 MAPK pathways.